FDA approves Merck's drug to treat rare, deadly lung disease

Merck bought the company developing the drug for $11.5 billion in 2021

Related Keywords

Paris ,France General ,France ,Saclay ,Marc Humbert ,Eliav Barr ,Acceleron Pharma ,Drug Administration ,Pulmonary Hypertension Reference Center ,Wall Street ,